ClinicalTrials.gov
public full text
Public Domain
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
This research study aims to predict treatment response to anti-angiogenic therapy (Avastin) using advanced magnetic resonance imaging (MRI) and spectroscopy (MRS) for Glioblastoma patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma#842962
- Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer#905994
- Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors#895911
- PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy#910026
- Combination Therapy for the Treatment of Diffuse Midline Gliomas#1127068
Record · ID 1173598
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive